These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The comparative effects of tolbutamide and the non-hypoglycemic analog carboxytolbutamide on guanylate cyclase activity. Vesely DL Horm Metab Res; 1986 Jan; 18(1):10-3. PubMed ID: 2868985 [TBL] [Abstract][Full Text] [Related]
5. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro. Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792 [TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats. Roquebert J; Grenié B Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518 [TBL] [Abstract][Full Text] [Related]
8. The circadian rhythm of guanylate cyclase and its interrelationship to rat liver chalone. Cannella NK; Vesely DL Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):207-17. PubMed ID: 6148775 [TBL] [Abstract][Full Text] [Related]
9. Direct effect of glibenclamide on guanylate cyclase activity in the rat in vitro. Vesely DL Diabetologia; 1982 Apr; 22(4):269-72. PubMed ID: 6124472 [TBL] [Abstract][Full Text] [Related]
10. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308 [TBL] [Abstract][Full Text] [Related]